Financial Futures’s AbbVie ABBV Stock Holding History

Financial Futures’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Hold	971	–	–	0.09%	69
2026 Q1	$211K	Buy	+971	New	+$215K	0.09%	70

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Financial Futures's ABBV Position: Q2 2026 in Review

Financial Futures held its AbbVie (ABBV) position steady in Q2 2026 at 971 shares worth $244K. The position accounts for 0.09% of the portfolio, ranked #69.

Financial Futures first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Financial Futures held 971 shares of AbbVie worth $244K as of Q2 2026.
Financial Futures left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of Financial Futures's portfolio in Q2 2026, its #69 holding.
Financial Futures first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Futures's 13F filing for Q2 2026, filed 27 Jul 2026.